Canada’s Drug Agency seeks up to 1 expert member for our pan-Canadian Oncology Drug Review Expert Review Committee (pERC). pERC issues reimbursement recommendations for oncology drugs to the participating public drug programs and cancer agencies (except Quebec). Apply by March 30.
Visit CDA-AMC's website for additional information — all nominations should be submitted by March 30, 2026 using CDA-AMC's online form. If you have questions, use CDA-AMC's contact form to submit an inquiry.